How much is Compounded tirzepatide without insurance?

From $199 a month paying cash, taken from the sellers of it on this site — nobody sells it under this name — the oldest of those readings on 2026-09-13. That is the lowest published figure, not what Compounded tirzepatide costs once titrated: no maintenance price is published for it.

What is the cheapest way to get Compounded tirzepatide without insurance?

Noom Med at $249 a month, of 7 verified routes to tirzepatide — each with its source and the date it was read, and listed in full above. That one is compounded rather than FDA approved, which is a legal status rather than a quality claim: it has no trial of its own and no approved label, and the pharmacy that makes it decides what is in it. Cheapest is not the same as best value: the table carries the maintenance price, because a starting-dose headline is not what anyone pays for long.

Is there a cheaper route to the same medication?

halfrx records 7 verified routes to tirzepatide. The cheapest is Noom Med at $249 a month, though that one is compounded rather than FDA approved, which is a legal status and not a quality claim. They are listed in full above with the date each was checked.

Does a cash price touch my deductible?

No. Paying cash is a transaction outside your plan, so it neither counts toward a deductible nor toward an out-of-pocket maximum. That cuts both ways: it is often cheaper today and it buys nothing toward the year's cap. Whether your plan covers this at all is a separate question — see does insurance cover it.

← What a year of treatment costs

What Compounded tirzepatide costs without insurance

from $199

a month, paying cash, at the lowest published price; the price once titrated is not published

checked 2026-09-13 — no maintenance-dose price

Last updated 2026-09-13 — the price on this page. Read and dated by Alex Seot.

How much does Compounded tirzepatide cost without insurance?

halfrx records Compounded tirzepatide from $199 a month paying cash, taken from the sellers of it on this site — nobody sells it under this name — the oldest of those readings on 2026-09-13; what it costs once titrated is not published. 7 routes to tirzepatide on this site carry a verified maintenance price, the cheapest Noom Med at $249 a month. Paying cash is a different transaction from being covered: the cash price does not touch a deductible. A plan that covers the drug can cost less or more than this, depending on the plan rather than on the drug. Anything past 45 days without a re-check is marked stale on this site rather than quietly aging.

The cheapest way to get Compounded tirzepatide, and every other verified route

The pages ranking for this question cover one seller. This is every seller on the site with a verified price for the same molecule, and the date each was read.

Route	A month, cash	What it is	Checked
Noom Med	$249	compounded, not FDA approved	2026-09-22
Found	$289	compounded, not FDA approved	2026-09-22
Henry Meds	$297	compounded, not FDA approved	2026-09-20
LillyDirect	$299	provider	2026-09-13
Medvi	$299	provider	2026-09-14
Zepbound	$449	branded, FDA approved	2026-08-19 — 50 days
Mounjaro	$499	branded, FDA approved	2026-09-21

Compounded tirzepatide price, terms and sources →Does insurance cover it →Medicaid by state →What it costs at the counter →When a generic can arrive →Free through the maker's program? →Everything ranked by price →

Where these Compounded tirzepatide figures come from

Everything here rests on third-party trackers rather than on Compounded tirzepatide's own published pricing, a regulator or a journal. Treat the figures as reported, not confirmed — this provider does not publish an all-in price we can read directly.

[1] GLP-1 Telehealth Price Report 2026secondary
[2] Mochi vs Henry Meds: two compounded providers under active litigationsecondary

Everything on Compounded tirzepatide

Compounded tirzepatide cost, answered

How much is Compounded tirzepatide without insurance?: From $199 a month paying cash, taken from the sellers of it on this site — nobody sells it under this name — the oldest of those readings on 2026-09-13. That is the lowest published figure, not what Compounded tirzepatide costs once titrated: no maintenance price is published for it.
What is the cheapest way to get Compounded tirzepatide without insurance?: Noom Med at $249 a month, of 7 verified routes to tirzepatide — each with its source and the date it was read, and listed in full above. That one is compounded rather than FDA approved, which is a legal status rather than a quality claim: it has no trial of its own and no approved label, and the pharmacy that makes it decides what is in it. Cheapest is not the same as best value: the table carries the maintenance price, because a starting-dose headline is not what anyone pays for long.
Is there a cheaper route to the same medication?: halfrx records 7 verified routes to tirzepatide. The cheapest is Noom Med at $249 a month, though that one is compounded rather than FDA approved, which is a legal status and not a quality claim. They are listed in full above with the date each was checked.
Does a cash price touch my deductible?: No. Paying cash is a transaction outside your plan, so it neither counts toward a deductible nor toward an out-of-pocket maximum. That cuts both ways: it is often cheaper today and it buys nothing toward the year's cap. Whether your plan covers this at all is a separate question — see does insurance cover it.

Every figure here carries its source and the date it was read, shown on each seller's own listing. Where a price is not published, this page says so. Information only, not medical advice.

What the FDA says about compounded medicine

A compounded drug is not an FDA-approved one. What that means, and what the agency has and has not evaluated, is its own to state.

Compounding and the FDA: questions and answers — What a compounded drug is, and what the FDA does and does not review before it is sold.
Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA — The FDA's own notice on compounded semaglutide and what it has not evaluated.